Keenova Therapeutics to Report First Quarter 2026 Financial Results on May 12, 2026
Go back to Keenova Therapeutics to Report First Quarter 2026 Financial Results on May 12, 2026| MALLINCKRODT PUBLIC LIMITED COMPANY (NYSE: MNK) | Delayed: 0.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.34 | 52 Week High | $85.83 | |||
| Open | $30.62 | 52 Week Low | $50.90 | |||
| Day High | $0.34 | P/E | 0.34 | |||
| Day Low | $0.34 | EPS | $1.00 | |||
| Volume | 84 | |||||
